About this event
Join us for an insightful panel discussion with leaders in the local Life Science community as they discuss their journeys navigating the complex decision-making process involved in determining the role of outsourcing in today’s business landscape. To focus on their core mission while launching and scaling a new business, Life Science CEOs, CFOs, and Boards need to decide what functions they should keep in-house and what they can outsource. This could include legal, finance, accounting, HR, IT, even CEO roles. Our panel will discuss the why, what, and when to “own it or outsource it” based on hands-on experience as CEOs, CFOs, and service providers.
Who should attend:
This session is designed for Life Science CEOs, CFOs, and Board Members.
Ulrich Thienel, Chief Executive Officer, ReAlta Life Sciences, Inc.
Scott Phillips, Chief Financial Officer, Halda Therapeutics and Normunity
Michael Lacrosse, Principal, CLA; former CFO, Industry Physics and Sr. Director Finance, iRobot
Moderator: Chesley Chen, Principal, Life Sciences, CLA
CLA exists to create opportunities for our clients, our people, and our communities through our industry-focused wealth advisory, outsourcing, audit, tax, and consulting services. With more than 7,500 people, 121 U.S. locations, and a global vision, we promise to know you and help you. For more information visit CLAconnect.com. Investment advisory services are offered through CliftonLarsonAllen Wealth Advisors, LLC, an SEC-registered investment advisor.